The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
 
Bahar Saberzadeh Ardestani
No Relationships to Disclose
 
Jeremy Clifton Jones
No Relationships to Disclose
 
Robert R. McWilliams
Stock and Other Ownership Interests - Zentalis
Consulting or Advisory Role - Zentalis
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Merck (Inst); Newlink Genetics (Inst)
 
David Tougeron
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AstraZeneca; MSD; Novartis; Pierre Fabre; Sanofi
Research Funding - AstraZeneca (Inst); BTG (Inst); MSD (Inst); Roche (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD Oncology; Sanofi
 
Thorvardur Ragnar Halfdanarson
Consulting or Advisory Role - Advanced Accelerator Applications (Inst); Camurus (Inst); Crinetics Pharmaceuticals (Inst); Ipsen (Inst); ITM Isotope Technologies Munich (Inst); Tersera; Viewpoint Molecular Targeting (Inst)
Research Funding - Advanced Accelerator Applications (Inst); Camurus (Inst); Crinetics Pharmaceuticals (Inst); ITM Isotope Technologies Munich (Inst); Novartis (Inst); Thermo Fisher Scientific (Inst); Turnstone Bio (Inst)
 
Rosine Guimbaud
No Relationships to Disclose
 
Joleen M. Hubbard
Employment - Allina Health Cancer Institute
Consulting or Advisory Role - Bayer (Inst); BeiGene (Inst); Incyte (Inst); Incyte (Inst); Merck; Seattle Genetics/Astellas; Taiho Oncology (Inst)
Research Funding - Bayer (Inst); G1 Therapeutics (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Pionyr (Inst); Seagen (Inst); Senhwa Biosciences (Inst); Taiho Pharmaceutical (Inst); Translational Research in Oncology (Inst); Treos Bio (Inst); Trovagene (Inst)
 
Clémence Flecchia
No Relationships to Disclose
 
Qian Shi
Honoraria - Chugai Pharma
Consulting or Advisory Role - Hoosier Cancer Research Network; Kronos Bio; Mirati Therapeutics; Regeneron; Yiviva
Research Funding - BMS (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Emily Linda Alouani
No Relationships to Disclose
 
Bassam Bassam Sonbol
Consulting or Advisory Role - Novartis Biociencias
Research Funding - Lilly (Inst); Taiho Oncology (Inst)
 
Jonathan Ticku
No Relationships to Disclose
 
Zhaohui Jin
No Relationships to Disclose
 
Julien Taieb
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Merck KGaA; MSD; Novartis; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Merck; MSD; Pierre Fabre; SERVIER
 
Frank A. Sinicrope
Employment - MedVal (I)
Stock and Other Ownership Interests - illumina
Honoraria - Targeted Oncology
Consulting or Advisory Role - Guardant Health; Roche
Research Funding - Ventana Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent royalty related to immune markers in colon cancer. Patent jointly held between myself and Roche/Ventana Medical Systems. (Inst)
Travel, Accommodations, Expenses - Guardant Health